Elena Zocchi,Mirko Magnone,Umberto Benatti,Giovanni Del Re,Antonio De Flora
申请号：
US16259155
公开号：
US20190280799A1
申请日:
2019.01.28
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The invention relates to the use of a very low dosage form of abscisic acid (ABA) or an in vivo hydrolysable conjugate thereof, preferably ABA-glucosyl ester (ABA-GE), for nutracentic/therapeutic use for controlling and/or preventing hyperglycaemia and weight gain in response to sugar intake with a reduction in insulin secret and an increase in muscle performance.
